History and Physical Examination
An 8-week-old girl presented with the chief complaint of a rapidly enlarging soft tissue mass located in the right shoulder/upper arm region. According to the parents, the mass was present at birth. Initially, this was thought to be a hematoma and observation was recommended. From the day of discharge (2 days postpartum) to presentation in clinic (at 8 weeks), the mass had enlarged rapidly, out of proportion relative to the child's growth ( Figs. 1, 2) . This was the firstborn child, product of a naturally conceived, full-term pregnancy with an uncomplicated vaginal delivery. There was adequate prenatal care, but the last ultrasound was performed at 20 weeks of gestation, and there was no prenatal diagnosis of a mass. Family history was noncontributory and the child was otherwise healthy.
On physical examination, the child was a welldeveloped, well-nourished 8-week-old girl in no acute distress. There was an obvious, large mass involving the entire upper arm and shoulder girdle, extending distally just proximal to the elbow and medially into the axillary region. The mass had a moderately firm consistency; there were areas of fluctuance, most notably in the superolateral region. There was no apparent pain on palpation. The mass was nonpulsatile and nonmobile, and the overlying skin was distended with increased vascularity. She had full passive and active range of motion (ROM) of the shoulder and elbow. The distal neurovascular examination was normal. The remainder of the examination was unremarkable.
Laboratory studies, including a basic metabolic panel and a complete blood count with differential, showed no abnormalities. Plain radiographs ( Fig. 3 ) and MRI scans ( Fig. 4 ) were obtained before further workup.
Given the size and appearance of the mass, malignancy was a concern; a needle biopsy was performed, followed by further screening workup. No other lesions were seen on the bone scan or CT of the chest, abdomen, and pelvis.
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Imaging Interpretation
Plain radiographs ( Fig. 3 ) showed a large soft tissue mass causing secondary humerus remodeling and slight valgus angulation but with no definitive bone invasion or scalloping. MRI showed this large lesion ( Fig. 4) better. It was a well-circumscribed, discrete, heterogeneous mass, relatively isointense to muscle on T1-weighted imaging, with variable areas of moderately increased signal on T2-weighted images. In the areas of solid tumor, cystic fluid-fluid levels and tubular structures with varying signal intensity also were evident. The mass extended medially into the axilla and from the superolateral aspect of the arm to the distal third of the triceps compartment. There was no direct invasion of the bone or periosteum.
Differential Diagnosis

Infantile hemangioma Vascular malformation Infantile myofibromatosis Congenital fibrosarcoma Rhabdomyosarcoma
The patient underwent needle biopsy of the lesion and histologic studies were performed (Figs. 5, 6) .
Based on the history, physical examination, laboratory studies, imaging studies, and histologic picture, what is the diagnosis and how should this lesion be treated? 
Histology Interpretation
The tumor was comprised of plump atypical spindle and ovoid cells arranged in a fascicular or herringbone-type pattern (Fig. 5 ). The cells appeared immature with minimal to mild eosinophilic fibrillary cytoplasm. There was minimal pleomorphism and frequent mitoses (10-11 per 5 high power fields.) The mass also contained scattered amounts of chronic mononuclear inflammatory cells (Fig. 6 ). Focal areas of hemorrhage and necrosis also were identified. Immunohistochemical staining for CD34, CD31, Factor VIII, HHF-35, SMA, desmin, S-100, and keratin were all negative. CD99 was positive. Ki-67 (proliferative index) was approximately 20% to 30%. FISH analysis for FKHR on 13q14, SYT on 18q11.2, and EWSR on 22q12 were negative. Reverse-transcription polymerase chain reaction (RT-PCR) was positive for ETV6/NTRK3 t(12;15) (q13;q25) translocation.
Diagnosis
Congenital or infantile fibrosarcoma
Discussion and Treatment
The differential diagnosis for a soft tissue mass in the extremity of an infant is broad, and includes benign and malignant processes, and congenital anomalies.
Hemangiomas are the most common tumor of infancy, occurring in 4% to 10% of infants [2, 15, 40] , and approximately 15% of these lesions involve the extremities. Congenital hemangiomas differ as they are fully grown by birth and do not have the characteristic postnatal rapid growth phase, tending to involute after 1 year [12] . Histologically, hemangiomas contain plump epithelial cells and lobules of benign-appearing capillaries, and have markers for vascular tumors [2, 15] . Vascular malformations can have similar clinical presentation at birth, but do not have the rapid growth pattern. MRI shows vascular channels and structures; lesions contain abnormal arterial, venous and lymphatic elements. Histologically these malformations are characterized by normal, mature vascular endothelium [26, 29] .
Infantile myofibromatosis is a benign spindle cell tumor [39] characteristically appearing within the first 2 years of life, but with as many as 60% present at birth [7, 35, 39] . Although MRI findings overlap with congenital fibrosarcoma, the vascular elements and cystic structures seen in our patient are not typical for myofibromatosis [21, 35] . Histologically, myofibromatosis may show frequent mitoses and a highly cellular spindle-cell proliferation, but its cytologic features are overall benign. Furthermore, it has a characteristic arrangement of plump spindle cells and immature-appearing cells surrounding thin, irregularly branching blood vessels [1, 7, 28] and positive SMA staining. Finally, as radiographic and histologic features of congenital fibrosarcoma and myofibromatosis often overlap, RT-PCR identification of the ETV6-NTRK3 fusion protein was critical for differentiation between the two entities [1] .
Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood [11, 18] , with approximately 10% occurring in infants, but fewer than 2% are congenital [11, 13, 31] . MRI features are nonspecific and similar to congenital fibrosarcoma [24, 25] , therefore the differentiation has to be made at a histologic level. Malignant rhabdomyoblasts [38] and immunohistochemical markers (SMA and desmin) [19] are present in rhabdomyosarcoma but not in congenital fibrosarcoma.
Congenital or infantile fibrosarcoma is a rare fibroblastic tumor, but is the most common soft tissue sarcoma in patients younger than 1 year, with 1 .
3 of cases present at birth [8, 9, 18, 36] . Extremities are the most common location, whereas truncal lesions carry a poorer prognosis [4, 32] . Although histologically identical to the adult-type fibrosarcoma, there are distinct cytogenetic and clinical characteristics [20] . Moreover, unlike its adult counterpart, congenital fibrosarcoma metastasizes in less than 10% of patients and carries a good prognosis, despite its ominous histologic appearance and locally aggressive behavior [3, 4, 14, 36] . Five-and 10-year survival rates are approximately 80% to 90% [6, 27, 30, 32] , and amputation rates appear to be declining [3, 8, 30] MRI findings are generally nonspecific, and show a well-circumscribed, heterogeneous mass, with vascular elements, areas of necrosis, and hemorrhage. The mass is typically isointense to muscle on T1-weighted images and heterogeneously hyperintense on T2-weighted images; gadolinium enhancement is variable [5, 24] . Although the lung is the most common site of metastases, congenital fibrosarcoma can metastasize to bone [3, 36] , with technetium-99 bone scan being useful for detection of these metastases.
Microscopically, congenital fibrosarcoma is a hypercellular, hyperchromatic, anaplastic spindle cells tumor arranged in a herringbone pattern, with frequent mitoses, necrosis, and hemorrhage [4] . Immunohistochemistry and cytogenetics often are needed, and show negative staining for SMA, S-100, desmin, CD31, and CD34 [19] . Congenital fibrosarcoma is characterized by a recurrent t(12;15)(p13;q25) rearrangement, producing the ETV6 (TEL):NTRK3 (neurotrophin-3 receptor) fusion protein identified by RT-PCR [20, 34] and not expressed by the adult-type fibrosarcoma [33] . Volume 469, Number 2, February 2011 Progressive Shoulder Mass in a Newborn 627
The treatment for congenital fibrosarcoma is multimodal, but the mainstay is surgical excision. Although the adoption of limb-salvage techniques has been proposed, the overall amputation rate for congenital fibrosarcoma still approaches 50% [3, 8, 30] , and it is not always clear which patients will have postsurgical local recurrence. Chemoresponsiveness of congenital fibrosarcoma is unclear [6, 30] , however neoadjuvant chemotherapy may be used, in an attempt to decrease tumor size and reduce the surgical morbidity. Chemotherapy also has been used for unresectable lesions [3, 16, 17, 22, 27, 37] . The most common regimen used combines vincristine, actinomycin D, and cyclophosphamide (VAC) [6, 30] ; its side effect is well established and is tolerable in infants [10, 22, 23] .
In our patient, neoadjuvant chemotherapy with three courses of VAC and one course exchanging actinomycin D for Adriamycin 1 (Pharmacia, Kalamazoo, MI) was used in an attempt to reduce the size of the tumor. Except for intratumoral bleeding, there was no significant change. Limb-salvage surgery was performed with microdissection of the brachial plexus and wide excision of the mass with free margins. Postoperative chemotherapy was not administered, owing to the poor response (\80% necrosis) and negative margins. At 2 years followup, the patient is continuously free of disease, and has recovered full ROM of her shoulder and elbow with no functional deficit.
We present the case of a patient with congenital fibrosarcoma treated with a limb-salvage strategy using neoadjuvant chemotherapy and wide surgical excision. It is still unclear whether there are specific attributes of congenital fibrosarcoma that confer chemoresponsiveness; our patient had some tumor necrosis without a reduction in tumor size. Nonetheless, given some successes reported in the literature, it is not unreasonable to include neoadjuvant chemotherapy in the overall treatment armamentarium when considering limb-salvage strategies. As we progress toward better comprehension of tumor characterization, behavior and treatment response patterns, we move away from highly morbid amputations as the mainstay of treatment for congenital fibrosarcoma.
